Showing results (1721-1730 of 1,880) with videos related to
Sort By:
Pageof 188
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.American Journal of Clinical Oncology|June 15, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and IIKenneth B Roberts, Anas Younes, David C Hodgson, et al.Mayo Clinic Proceedings|April 29, 1998
Hemoglobin Old Dominion/Burton-upon-Trent, beta 143 (H21) His-->Tyr, codon 143 CAC-->TAC--a variant with altered oxygen affinity that compromises measurement of glycated hemoglobin in diabetes mellitus: structure, function, and DNA sequenceG E Elder, T R Lappin, A B Horne, et al.International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation TherapyBradford S Hoppe, Kathleen M McCarten, Qinglin Pei, et al.Plos One|March 29, 2019
A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challengesJeffrey G Shaffer, John S Schieffelin, Michael Gbakie, et al.American Journal of Clinical Oncology|September 20, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and IISughosh Dhakal, Ranjana Advani, Leslie K Ballas, et al.Journal of the American College of Radiology : JACR|October 4, 2014
ACR appropriateness criteria follow-up of Hodgkin lymphomaChul S Ha, David C Hodgson, Ranjana Advani, et al.American Journal of Clinical Oncology|November 20, 2015
ACR Appropriateness Criteria® Diffuse Large B-Cell LymphomaBouthaina S Dabaja, Ranjana Advani, David C Hodgson, et al.Oral Oncology|September 26, 2022
Outcomes for recurrent oral cavity squamous cell carcinomaKevin J Contrera, Mark E Zafereo, Dan Yaniv, et al.Bioorganic & Medicinal Chemistry Letters|October 11, 2012
2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.Pageof 188